These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1349258)

  • 1. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions.
    Grönneberg R; Zetterström O
    Clin Exp Allergy; 1992 Feb; 22(2):257-63. PubMed ID: 1349258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 2. Effect on the late phase reaction.
    Grönneberg R; Zetterström O
    Allergy; 1990 Jul; 45(5):340-6. PubMed ID: 2165750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 1. Dose response relation and duration of effect on the early wheal and flare response.
    Grönneberg R; Zetterström O
    Allergy; 1990 Jul; 45(5):334-9. PubMed ID: 1974124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin.
    Grönneberg R; Raud J
    Allergy; 1996 Oct; 51(10):685-92. PubMed ID: 8904995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent inhibition by terbutaline of anti-human IgE skin responses in atopic and non-atopic subjects.
    Grönneberg R; Strandberg K; Stålenheim G; Zetterström O
    Allergy; 1985 Jan; 40(1):27-35. PubMed ID: 2579597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disodium cromoglycate on anti-IgE induced early and late skin response in humans.
    Grönneberg R; Zetterström O
    Clin Allergy; 1985 Mar; 15(2):167-71. PubMed ID: 3922643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity.
    Lindberg S; Khan R; Runer T
    Eur J Pharmacol; 1995 Oct; 285(3):275-80. PubMed ID: 8575514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine.
    Ketchell RI; Jensen MW; Spina D; O'Connor BJ
    Eur Respir J; 2002 Apr; 19(4):611-6. PubMed ID: 11998988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect in man of anti-allergic drugs on the immediate and late phase cutaneous allergic reactions induced by anti-IgE.
    Grönneberg R; Strandberg K; Stålenheim G; Zetterström O
    Allergy; 1981 Apr; 36(3):201-8. PubMed ID: 7195156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients.
    Grönneberg R; van Hage-Hamsten M; Halldén G; Hed J; Raud J
    Allergy; 1996 Sep; 51(9):640-6. PubMed ID: 8899116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of terbutaline, a beta 2-adrenergic receptor stimulating compound, on cutaneous reponses to histamine, allergen, compound 48/80, and trypsin.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1979 Oct; 34(5):303-9. PubMed ID: 44669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction.
    Nix A; Nichol GM; Robson A; Barnes PJ; Chung KF
    Br J Clin Pharmacol; 1990 Mar; 29(3):321-4. PubMed ID: 1968754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the late phase response to anti-IgE in humans by indomethacin.
    Grönneberg R; Zetterström O
    Allergy; 1985 Jan; 40(1):36-41. PubMed ID: 2579598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological support of antagonism of allergen-induced mast cell mediator release in human skin by a beta-2-agonist.
    Grönneberg R; Lagerholm B
    Allergy; 1986 Jan; 41(1):71-4. PubMed ID: 2421600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the late phase reaction to anti-IgE by previous mast cell activation with compound 48/80.
    Grönneberg R
    Allergy; 1984 Feb; 39(2):119-23. PubMed ID: 6608283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
    Linden M
    Br J Pharmacol; 1992 Sep; 107(1):156-60. PubMed ID: 1358381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
    Jeppsson AB; Nilsson E; Waldeck B
    Eur J Pharmacol; 1994 May; 257(1-2):137-43. PubMed ID: 8082695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1980 Jul; 35(5):409-12. PubMed ID: 6108725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.